Top Markets
Coin of the day
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
Rankning i aktier #30194
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Aktiekurs
$0.21877731
Marknadsvärde
$17.53M
Förändring (1 dag)
-1.57%
Förändring (1 år)
-16.15%
Land
TW
Handel TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Kategori

Historik för aktiesplit för TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Aktien TaiwanJ Pharmaceuticals Co., Ltd. (symbol: 6549) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 19, 2026.
En 6549-aktie köpt före Aug 19, 2026 motsvarar nu 0 6549-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR